Laigo Bio

Biotechnology Research • Yalelaan 62, Life Sciences Incubator Rm 2.05 Utrecht Science Park, Netherlands • 1-10 Employees

Company overview

Headquarters	Yalelaan 62, Life Sciences Incubator Rm 2.05 Utrecht Science Park, Utrecht, 3584 CM, NL
Website	laigobio.com
Employees	1-10
Socials

Key Contact at Laigo Bio

Madelon Maurice

Scientific founder and scientific lead

Laigo Bio Email Formats

Laigo Bio uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@laigobio.com), used 57.1% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@laigobio.com	57.1%
{first name}.{last name}	john.doe@laigobio.com	42.9%

About Laigo Bio

Laigo's proprietary SureTAC platform empowers us to rapidly develop first-in-class dual targeted therapies that eliminate disease-driving membrane targets using straightforward bispecific antibody technology. We are committed to exploring an ever-evolving universe of new targets, including those currently considered undruggable, and we are open to strategic partnerships to make meaningful advancements in treating diseases that lack effective treatment options today. Laigo Bio is where innovation meets life-changing solutions, forging a path toward a healthier tomorrow. #TPD #Protac #membraneprotein #bispecificantibody #antibody #proteindegradation #roteindegrader #LaigoBio #oncology #neurobiology #immunology #SureTACs

Laigo Bio revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding